2020
DOI: 10.11604/pamj.2020.35.127.21113
|View full text |Cite
|
Sign up to set email alerts
|

Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…Comorbidity of the sickle cell trait and OCA was recently described in the DRC in 221 individuals. This study demonstrated that the frequency of the sickle cell trait was equivalent in the two groups (82 albinos including 18.3% carriers of HbS and 139 non-albinos including 18% carriers of HbS) [ 20 ]. This study did not report any case of SCD in this population but the authors concluded that it is important to sensitize this category of people to be screened for hemoglobin S [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Comorbidity of the sickle cell trait and OCA was recently described in the DRC in 221 individuals. This study demonstrated that the frequency of the sickle cell trait was equivalent in the two groups (82 albinos including 18.3% carriers of HbS and 139 non-albinos including 18% carriers of HbS) [ 20 ]. This study did not report any case of SCD in this population but the authors concluded that it is important to sensitize this category of people to be screened for hemoglobin S [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…This study demonstrated that the frequency of the sickle cell trait was equivalent in the two groups (82 albinos including 18.3% carriers of HbS and 139 non-albinos including 18% carriers of HbS) [ 20 ]. This study did not report any case of SCD in this population but the authors concluded that it is important to sensitize this category of people to be screened for hemoglobin S [ 20 ]. SCD patients present with numerous acute and chronic complications that contribute to early mortality and, consequently, national medical costs [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation